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Evaluating expression of miR-100 in peripheral blood mononuclear cells of esophageal 
cancer patients and normal controls 
Abstract: 
Background and Objective: Esophageal Cancer (EC) is one of the most aggressive and 
lethal cancers worldwide. EC consists of two main pathologic types, namely esophageal 
squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (ADC). ESCC is the most 
prevalent form in countries like China and Iran. This study evaluated expression of miR-100 in 
peripheral blood mononuclear cells of ESCC.  
Methods: Blood samples were taken from 40 patients with pathologic diagnosis and 40 
healthy subjects without any history of cancer in the family. Then PBMC and RNA were 
extracted and after the synthesis of CDNA by Stem-loop method, gene expression assay was 
evaluated using Quantitative Real-Time RT PCR technique. SNORD47 gene (NR_002746) was 
also used as an internal reference. 
Results: Gene expression analysis using Pfaffl method and REST software revealed not 
significant differences of PBMC miR-100 between patients and controls (p value: 0/342). To 
best our knowledge this was the first study that examined the level of miR-100 in PBMC of 
patients with ESCC. 
Conclusion: In conclusion, the PBMC expression of miR-100 does not represent a potential 
biomarker of ESCC. 
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